Akèy › Kansè kolon
Etid klinik pou Kansè kolon ap rekrite nan Etazini
101 etid pou Kansè kolon ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA22 etid
- New York City, NY22 etid
- Houston, TX20 etid
- Nashville, TN16 etid
- Los Angeles, CA16 etid
- Arlington, VA15 etid
- St. Louis, MO15 etid
- San Antonio, TX14 etid
- Tampa, FL13 etid
- Baldwin Park, CA13 etid
- Chicago, IL13 etid
- Baltimore, MD13 etid
- Washington, DC12 etid
- Durham, NC12 etid
- Seattle, WA12 etid
- Grand Rapids, MI11 etid
- Columbus, OH11 etid
- Cincinnati, OH11 etid
- Sacramento, CA10 etid
- San Diego, CA10 etid
- Aurora, CO9 etid
- Pittsburgh, PA9 etid
- Denver, CO9 etid
- Portland, OR9 etid
- Jacksonville, FL9 etid
- Atlanta, GA9 etid
- Philadelphia, PA9 etid
- Omaha, NE9 etid
- Salt Lake City, UT9 etid
- Rochester, MN9 etid
- Phoenix, AZ9 etid
- Edison, NJ8 etid
- Cleveland, OH8 etid
- Kansas City, MO8 etid
- Cedar Rapids, IA8 etid
- Dallas, TX8 etid
- Lexington, KY8 etid
- Sioux Falls, SD7 etid
- Green Bay, WI7 etid
- Boise, ID7 etid
Pa eta
- Alabama6 etid
- Arizona18 etid
- Arkansas6 etid
- Ayiti4 etid
- Colorado19 etid
- Connecticut10 etid
- Delaware3 etid
- Distrik Columbia5 etid
- Florid29 etid
- Georgia14 etid
- Idaho8 etid
- Illinois18 etid
- Indiana7 etid
- Iowa9 etid
- Kalifòni41 etid
- Kansas7 etid
- Kentucky9 etid
- Lwizyàn8 etid
- Main5 etid
- Maryland22 etid
- Massachusetts24 etid
- Michigan18 etid
- Minnesota18 etid
- Mississippi5 etid
- Missouri18 etid
- Montana7 etid
- Nebraska10 etid
- Nevada5 etid
- New Jersey15 etid
- New Mexico7 etid
- New York27 etid
- North Carolina20 etid
- North Dakota6 etid
- Ohio23 etid
- Oklahoma7 etid
- Oregon10 etid
- Pennsylvania18 etid
- Rhode Island3 etid
- South Carolina5 etid
- South Dakota8 etid
- Tennessee21 etid
- Texas29 etid
- Utah13 etid
- Virginia23 etid
- Washington13 etid
- West Virginia5 etid
- Wisconsin11 etid
- Wyoming3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07085091PRE-ISPY Phase I/II Oncology Platform Program
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT05868226Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07529808A Study of PHN-012 in Patients With Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07127874A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06997497Genomic Services Research Program
Ap rekriteEtid obsèvasyon
1 Month – 105 Years · Tout sèks · Mizajou Sep 28, 2026 · NCT02595957Collection of Blood From Patients With Cancer
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT00034216Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07222800Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551Prehabilitation in High-risk Oncologic Surgery
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07638410A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07629960A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07705334A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07213609EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06263088A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07284849ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444Evaluating Novel Therapies in ctDNA Positive GI Cancers
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05482516Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
Ap rekrite
Laj 18 a 50 · Tout sèks · Mizajou Sep 11, 2026 · NCT06202183Resilience and Equity in Aging, Cancer, and Health (REACH)
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT04674267A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07058012Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Ap rekriteEtid obsèvasyon
Laj 18 a 50 · Fanm · Mizajou Sep 2, 2026 · NCT06904365Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07283939Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Ap rekrite
Laj 45 a 70 · Tout sèks · Mizajou Sep 2, 2026 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05174169Family Communications After Genetic Testing
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07143487Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.